An observational study in Coronary Vasospasm, Coronary Microvascular Dysfunction and Non-Obstructive Coronary Atherosclerosis, sponsored by Radboud University Medical Center. Enrolling by invitation at 15 sites in Netherlands. Per ClinicalTrials.gov, last updated 2024-05-14.
Sponsored by Radboud University Medical Center · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The goal of this registry is to collect data on patients referred for clinically indicated coronary vasomotor function test (CFT) and answer different questions on prevalence, safety and outcomes. The registry is observational. Patients receive yearly online questionnaires on their anginal complaints for 5 years after their CFT.
27 studies on the registry are indexed under Coronary Vasospasm; 7 are open to participants now.
This study's planned enrollment of 2,000 is above the median of 380 across 12 observational studies indexed under Coronary Vasospasm.
Browse Coronary Vasospasm studies →Radboud University Medical Center is the lead sponsor of 986 studies on the registry; 135 are open to participants now.
Of its 6 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
All patients referred for clinically indicated CFT are eligible
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Collection of data on anginal complaints, use of medication and major adverse cardiac events (MACE) by means of online patient questionnaires
Diagnostic Test: Coronary Function Test · Other: Patient questionnaires
Comparison of patient reported outcomes of different endotype groups Collection of data on anginal complaints, use of medication and MACE by means of online patient questionnaires
Diagnostic Test: Coronary Function Test · Other: Patient questionnaires
All participants are referred for a clinically indicated coronary function test
All participants that consent will receive yearly followup questionnaires for 5 years after their initial consent
Prevalence of coronary vasomotor dysfunction
Can be handled as dichotomous outcome with normal vs abnormal coronary function test (CFT) results. Alternatively, can also be handled as categorical outcome with the following categories. 1. Normal CFT results 2. Vasospastic endotype (epicardial or microvascular); tested by acetylcholine provocation 3. Microvascular dysfunction endotype (decreased coronary flow reserve or increased index of microvascular resistance); tested by bolus thermodilution, optionallly with additional continuous thermodilution method 4. Mixed endotype
Time frame: Baseline
Angina burden
Measured by Seattle Angina Questionnaire summary score, 0-100 with higher scores indicating better (functional) status.
Time frame: Baseline and every year up to 5 years after baseline
Experienced quality of life
Measured by Short Form 36, 0-100 with higher scores indicating better quality of life
Time frame: Baseline and every year up to 5 years after baseline
Plan to share: No — Only participating centers that signed the joint data registry agreement can make a request for data after approval of steering committee.
No publications or documents are linked to this record.
Started Oct 2020 (actual). Primary completion is estimated for Oct 2030, 120 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Radboud University Medical Center →